Tech Company Financing Transactions
Solace Pharmaceuticals Funding Round
On 3/31/2008, Solace Pharmaceuticals landed $6.7 million in investment from InterWest Partners and Polaris Partners.
Transaction Overview
Company Name
Announced On
3/31/2008
Transaction Type
Venture Equity
Amount
$6,749,000
Round
Undisclosed
Investors
InterWest Partners (Christopher Ehrlich)
Polaris Partners (Kevin Bitterman)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
Four Cambridge Center 2nd floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Solace was co-founded in March 2006 by PureTech Ventures and a preeminent team of scientific, clinical, regulatory and drug development experts who are collaborating to translate groundbreaking scientific discoveries in pain biology into innovative, effective therapeutic strategies for addressing chronic pain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eliot Forster
Vice President
Alasdair Naylor
Browse more venture capital transactions:
Prev: 3/31/2008: Feder8 venture capital transaction
Next: 3/31/2008: F-Origin venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs